Aster DM Healthcare [ASTERDM] vs Pfizer [PFIZER] Detailed Stock Comparison

Aster DM Healthcare
NSE
Loading...

Pfizer
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Aster DM Healthcare wins in 9 metrics, Pfizer wins in 11 metrics, with 0 ties. Pfizer appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Aster DM Healthcare | Pfizer | Better |
---|---|---|---|
P/E Ratio (TTM) | 95.22 | 30.37 | Pfizer |
Price-to-Book Ratio | 8.78 | 5.53 | Pfizer |
Debt-to-Equity Ratio | 55.26 | 2.57 | Pfizer |
PEG Ratio | -0.97 | 30.48 | Aster DM Healthcare |
EV/EBITDA | 38.34 | 29.31 | Pfizer |
Profit Margin (TTM) | 7.55% | 33.65% | Pfizer |
Operating Margin (TTM) | 13.37% | 35.96% | Pfizer |
EBITDA Margin (TTM) | 13.37% | 35.96% | Pfizer |
Return on Equity | 147.28% | 19.65% | Aster DM Healthcare |
Return on Assets (TTM) | 81.40% | 9.32% | Aster DM Healthcare |
Free Cash Flow (TTM) | $683.20M | $6.32B | Pfizer |
Dividend Yield | 1.05% | 1.27% | Pfizer |
1-Year Return | 54.85% | -8.94% | Aster DM Healthcare |
Price-to-Sales Ratio (TTM) | 7.43 | 10.23 | Aster DM Healthcare |
Enterprise Value | $318.72B | $206.66B | Aster DM Healthcare |
EV/Revenue Ratio | 7.56 | 9.06 | Aster DM Healthcare |
Gross Profit Margin (TTM) | 77.07% | 65.79% | Aster DM Healthcare |
Revenue per Share (TTM) | $84 | $499 | Pfizer |
Earnings per Share (Diluted) | $6.36 | $168.01 | Pfizer |
Beta (Stock Volatility) | 0.06 | 0.13 | Aster DM Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Aster DM Healthcare vs Pfizer Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Aster DM Healthcare | -1.22% | 1.85% | 0.96% | 5.56% | 45.79% | 16.29% |
Pfizer | 4.33% | 6.14% | -1.53% | 20.95% | 27.52% | 0.39% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Aster DM Healthcare | 54.85% | 190.18% | 333.04% | 250.87% | 250.87% | 250.87% |
Pfizer | -8.94% | 25.33% | 15.73% | 134.58% | 362.54% | 552.22% |
Performance & Financial Health Analysis: Aster DM Healthcare vs Pfizer
Metric | ASTERDM | PFIZER |
---|---|---|
Market Information | ||
Market Cap | ₹313.17B | ₹233.40B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 665,171 | 17,573 |
90 Day Avg. Volume | 997,639 | 30,570 |
Last Close | ₹605.60 | ₹5,328.00 |
52 Week Range | ₹382.30 - ₹675.00 | ₹3,701.00 - ₹6,451.15 |
% from 52W High | -10.28% | -17.41% |
All-Time High | ₹675.00 (Jul 03, 2025) | ₹6,451.15 (Sep 02, 2024) |
% from All-Time High | -10.28% | -17.41% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.08% | 0.08% |
Quarterly Earnings Growth | -0.98% | 0.85% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | 0.34% |
Operating Margin (TTM) | 0.13% | 0.36% |
Return on Equity (TTM) | 1.47% | 0.20% |
Debt to Equity (MRQ) | 55.26 | 2.57 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹68.98 | ₹921.88 |
Cash per Share (MRQ) | ₹26.98 | ₹608.26 |
Operating Cash Flow (TTM) | ₹54.10B | ₹6.60B |
Levered Free Cash Flow (TTM) | ₹53.78B | ₹5.01B |
Dividends | ||
Last 12-Month Dividend Yield | 1.05% | 1.27% |
Last 12-Month Dividend | ₹6.00 | ₹70.00 |
Valuation & Enterprise Metrics Analysis: Aster DM Healthcare vs Pfizer
Metric | ASTERDM | PFIZER |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 95.22 | 30.37 |
Forward P/E | 64.36 | 30.48 |
PEG Ratio | -0.97 | 30.48 |
Price to Sales (TTM) | 7.43 | 10.23 |
Price to Book (MRQ) | 8.78 | 5.53 |
Market Capitalization | ||
Market Capitalization | ₹313.17B | ₹233.40B |
Enterprise Value | ₹318.72B | ₹206.66B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 7.56 | 9.06 |
Enterprise to EBITDA | 38.34 | 29.31 |
Risk & Other Metrics | ||
Beta | 0.06 | 0.13 |
Book Value per Share (MRQ) | ₹68.98 | ₹921.88 |
Financial Statements Comparison: Aster DM Healthcare vs Pfizer
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTERDM | PFIZER |
---|---|---|
Revenue/Sales | ₹10.78B | ₹5.92B |
Cost of Goods Sold | ₹2.47B | ₹2.02B |
Gross Profit | ₹8.31B | ₹3.89B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹1.44B | ₹2.11B |
EBITDA | ₹2.35B | ₹2.72B |
Pre-Tax Income | ₹1.36B | ₹4.26B |
Income Tax | ₹428.80M | ₹948.60M |
Net Income (Profit) | ₹935.60M | ₹3.31B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTERDM | PFIZER |
---|---|---|
Cash & Equivalents | ₹1.65B | ₹4.95B |
Total Current Assets | ₹19.01B | ₹35.13B |
Total Current Liabilities | ₹8.79B | ₹5.70B |
Long-Term Debt | ₹18.29B | ₹676.20M |
Total Shareholders Equity | ₹36.51B | ₹42.17B |
Retained Earnings | N/A | ₹24.36B |
Property, Plant & Equipment | ₹36.28B | ₹1.72B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTERDM | PFIZER |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTERDM | PFIZER |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 665,171 | 17,573 |
Average Daily Volume (90 Day) | 997,639 | 30,570 |
Shares Outstanding | 498.21M | 45.75M |
Float Shares | 192.01M | 15.12M |
% Held by Insiders | 0.52% | 0.67% |
% Held by Institutions | 0.32% | 0.17% |
Dividend Analysis & Yield Comparison: Aster DM Healthcare vs Pfizer
Metric | ASTERDM | PFIZER |
---|---|---|
Last 12-Month Dividend | ₹6.00 | ₹70.00 |
Last 12-Month Dividend Yield | 1.05% | 1.27% |
3-Year Avg Annual Dividend | ₹41.33 | ₹46.67 |
3-Year Avg Dividend Yield | 11.45% | 0.58% |
3-Year Total Dividends | ₹124.00 | ₹140.00 |
Ex-Dividend Date | Feb 10, 2025 | Jul 09, 2025 |